Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vive Crop Protection
Mississauga, Ontario, Canadavivecrop.ca ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Vive has multiple EPA-approved commercial products on the market. Its technology enables simultaneous application of fertilizers and crop protection agents with improved efficacy. Recent launches like Phobos® FC fungicide have exceeded sales expectations. The company’s portfolio includes both synthetic and biological actives delivered via its patented nanotechnology platform. No clinical results as it does not develop human therapeutics.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Small moleculeBiologicNanoparticle
- Industry
- Agriculture & AgTech
02
Partnerships
Arysta LifeScience/BioScience Solutions Group partnership for formulation innovation
Beyond the preview
Go deeper on Vive Crop Protection.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vive Crop Protection.